Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presentation

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presenter: Seiji Habara

June 30, 2015

Prognostic Role of Restenosis in 10,004 Patients Undergoing Routine Control Angiography

Presentation

Prognostic Role of Restenosis in 10,004 Patients Undergoing Routine Control Angiography

Presenter: S. Cassese

October 21, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.